Objectives: To determine the effect of chlorhexidine varnish on the prevention of caries in permanent first molars.
Methods: Two groups of 6-7-year-old school children were followed up in a clinical trial, a group of 86 children whose teeth were treated with a chlorhexidine-thymol varnish (Cervitec) and a control group of 95 children. The varnish was reapplied every 3 months and the caries increments were compared at 24 months.
Results: The DFS (decayed and filled surfaces in permanent first molars) increment in the control group (mean = 1.85; SD = 2.27) was higher than in the test group (mean = 0.95; SD = 1.38), resulting in a 48.6% caries reduction. This difference was statistically significant (P = 0.032).
Conclusions: Chlorhexidine-thymol varnish is effective in preventing caries in permanent first molars.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1034/j.1600-0528.2002.00061.x | DOI Listing |
Indian J Dent Res
July 2019
Department of Microbiology, Faculty of Pharmacy, Damascus University, Damascus, Syria.
Background: Streptococcus mutans is considered as the main pathogenic factor for initiation and progression of dental caries. Fluoride is one of the most effective agents used to control caries. Chlorhexidine (CHX) is the most antimicrobial agent against S.
View Article and Find Full Text PDFCaries Res
April 2019
Department of Community Dentistry, Faculty of Dentistry, Semmelweis University, Budapest, Hungary.
Unlabelled: The aim of this study was to investigate the effects of Cervitec Plus® on the level of mutans streptococcus (SM) and lactobacillus (LB) colonies and the development of white spot lesions (WSLs) in patients with fixed orthodontic appliances. Informed consent was obtained from 32 volunteers (age 16.5 ± 2.
View Article and Find Full Text PDFJ Indian Soc Pedod Prev Dent
March 2018
Department of Pedodontics, Pacific Dental College and Hospital, Udaipur, Rajasthan, India.
Background: There is a need for exploration of the role of chemotherapeutic agents and its role in the prevention of early childhood caries (ECC) and its recurrence.
Aim: The aim of this study was two-fold: (1) To compare the antimicrobial efficacy of three commonly used chemotherapeutic agents in the prevention of ECC in comparison with a control and (2) To ascertain the role of chemotherapeutic agents in the prevention of ECC.
Materials And Methods: Sixty children with ECC in the age group 3-6 years were randomly allocated into four groups.
Objective: The aim of this study was to investigate dentin protection of different desensitizing varnishes (light- and self-curing) during acid action/abrasion stress and thermocyclic loading in vitro.
Methods: Dentin discs of 2 mm thickness were cut from 120 human molars, embedded, and polished. Specimens were randomized into five groups (n=24): A, negative control; B, Gluma Desensitizer; C, Cervitec plus (self-curing); D, Seal&Protect; and E, Admira Protect (light-curing).
Pediatr Dent
September 2017
Center for Evidence-Based Dentistry, American Dental Association, Chicago, Ill., USA; Evidence-Based Dentistry Unit and Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Chile, Santiago, Chile; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Background: National Health and Nutrition Examination Survey 2011-2012 data indicated that, in the United States, nearly onefourth of children and over one-half of adolescents experienced dental caries in their permanent teeth. The purpose of this review was to summarize the available clinical evidence regarding the effect of dental sealants for the prevention and management of pit-and-fissure occlusal carious lesions in primary and permanent molars, compared with a control without sealants, with fluoride varnishes, or with other head-to head comparisons.
Type Of Studies Reviewed: The authors included parallel and split-mouth randomized controlled trials that included at least 2 years of follow-up, which they identified using MEDLINE (via PubMed), Embase, LILACS, the Cochrane Central Register of Controlled Trials, and registers of ongoing trials.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!